Remdesivir use a boon for COVID patients with early use, Bengaluru study finds
An Indian study suggests early use of remdesivir to treat patients of COVID-19 to be beneficial, if given early. Remdesivir, if administered within nine days of the onset of symptoms, improves survival outcomes for those with moderate-to-severe cases of COVID-19 – the disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) or, simply, coronavirus. …
Remdesivir use a boon for COVID patients with early use, Bengaluru study finds Read More »
